MedPath

StO2 Performance Measured on Admission to the Emergency Department in the Assessment of Drug Poisoning

Not Applicable
Completed
Conditions
Drug Poisoning
Interventions
Device: Measurement of StO2
Registration Number
NCT01861262
Lead Sponsor
University Hospital, Toulouse
Brief Summary

The primary purpose of the protocol is to evaluate the StO2 performance measured at the admission to the emergency department to identify hemodynamic failure at the admission or within the first three hours of monitoring patients with drug poisoning.

The study hypotheses are:

* The early detection of hypoperfusion by StO2, essential to prevent the development of collapse.

* To limit hemodynamic failure effects, reduce morbidity and mortality of drug poisoning, hospital stay and cost.

Detailed Description

The procedure is a measurement and non-invasive monitoring system of percentage of oxygen saturation of haemoglobin in tissues using infrared technology. The system used in the study is the tissue oxygenation monitor InSpectraTM StO2 Spot Check, Model 300 consisting of a clamp applied to the base of the thumb of the patient.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
300
Inclusion Criteria
  • admitted to the emergency department,
  • whose pattern of hospitalization is drug poisoning, defined on data from the patient's interrogation or his family if the patient is not able to answer,
  • Written informed consent signed by the patient or, if he's unable to sign, by a companion,
  • Affiliated to medical insurance
Exclusion Criteria
  • Patients without thenar eminence or having a disease of the thenar,
  • Refusal to participate in the study,
  • Participation in another biomedical research,
  • Patient under guardianship, trusteeship or judicial protection,
  • Pregnant women or nursing mothers

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Measurement of StO2Measurement of StO2The procedure is a measurement and non-invasive monitoring system of percentage of oxygen saturation of haemoglobin in tissues using infrared technology. The system used in the study is the tissue oxygenation monitor InSpectraTM StO2 Spot Check, Model 300 consisting of a clamp applied to the base of the thumb of the patient.
Primary Outcome Measures
NameTimeMethod
StO2 performance measured to identify hemodynamic failure.Outcome measure is assessed during three hours after the admission to the emergency department.
Secondary Outcome Measures
NameTimeMethod
StO2 distributionOutcome measure is assessed during three hours after the admission to the emergency department.
StO2 threshold value to predict the onset of hemodynamic failureOutcome measure is assessed during three hours after the admission to the emergency department.

Trial Locations

Locations (1)

University Hospital of Toulouse

🇫🇷

Toulouse, Midi-Pyrenees, France

© Copyright 2025. All Rights Reserved by MedPath